| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 152.23B | 146.52B | 129.68B | 121.27B | 117.72B | 131.27B |
| Gross Profit | 138.70B | 134.58B | 123.36B | 114.38B | 114.01B | 121.68B |
| EBITDA | 28.25B | 37.59B | 28.03B | 23.25B | 25.20B | 22.03B |
| Net Income | 21.28B | 20.61B | 12.83B | 9.65B | 11.76B | 9.42B |
Balance Sheet | ||||||
| Total Assets | 13.28T | 13.45T | 13.24T | 12.52T | 13.54T | 11.86T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 2.65T | 3.06T | 2.80T | 4.34T | 2.63T |
| Total Debt | 889.59B | 1.70T | 1.77T | 941.78B | 4.01T | 1.30T |
| Total Liabilities | 12.88T | 13.06T | 12.80T | 12.11T | 13.12T | 11.42T |
| Stockholders Equity | 393.16B | 380.48B | 442.68B | 403.35B | 416.81B | 436.05B |
Cash Flow | ||||||
| Free Cash Flow | 33.66B | 33.66B | 983.81B | -1.37T | 1.73T | 1.16T |
| Operating Cash Flow | 39.05B | 39.05B | 988.14B | -1.36T | 1.74T | 1.17T |
| Investing Cash Flow | -328.51B | -328.51B | -703.01B | -172.00B | -16.14B | -171.64B |
| Financing Cash Flow | -9.05B | -9.05B | -19.16B | -4.82B | -4.03B | -32.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥317.89B | 7.80 | ― | 1.95% | 19.69% | 50.61% | |
76 Outperform | ¥322.60B | 9.60 | ― | 2.94% | 1.91% | 9.73% | |
76 Outperform | ¥356.21B | 9.10 | 8.52% | 2.12% | 22.44% | 59.32% | |
72 Outperform | ¥331.55B | 10.18 | ― | 3.01% | 19.69% | 70.91% | |
68 Neutral | ¥362.88B | 11.65 | 3.95% | 2.19% | 9.29% | 28.34% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
54 Neutral | ¥338.89B | 10.57 | 4.74% | 3.38% | 5.47% | ― |